Antibody-Drug Conjugates (ADCs) are a core technology in tumor-targeted therapy, featuring a ‘tripartite integrated design’ of ‘precision carrier-stable linker-potent payload’. The carrier component ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results